Ann: Emyria secures clinical-grade MDMA supply for Aust patients, page-5

First 5 Last

Share
Profile

Follow
PVPVG

900 Posts.

378

13/02/23

10:56

Post #: 66211899
Share

Originally posted by Scooty: ↑

I’m not sure what to make of this announcement. We’re in the business of developing MDMA like compounds for therapeutic use, yet we’ve just gone and bought some from a supplier and it seems like we’re going to move into more of an enabler type role than as a supplier ourselves.

Its a little confusing and I guess the concern is with what about all the companies research and development? Does the rescheduling mean “MDMA LIKE” research is not necessary now as actual MDMA is now going to be available?

Please note I sold last week on the hype, until the pathway became clearer for commercial opportunities. It’s exciting but I’m not sure where we fit into this market right now.

Expand

Oh mate where to start..

This company is in an incredible position to take full advantage of the rule change, making money on multiple aspects of it and will be able to perform its trials for MDMA like durgs targeting novel treatments in Australia.

I wrote a whole thing explaining everything about 10 minutes ago but Hotcopper had a moment and its lost now, I'll re write it later but all the information is out there.

EMD Price at posting: 27.0¢ Sentiment: None Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

BOE

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Clarity confidence – and share price – up on bumper $203M institutional placement

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.1¢		Change 0.000(0.00%)		Mkt cap ! $25.06M

Open	High	Low	Value	Volume
4.2¢	4.2¢	3.8¢	$142.7K	3.545M

Buyers (Bids)

No.	Vol.	Price($)
8	474470	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.1¢	105531	2

View Market Depth

No.	Vol.	Price($)
8	474470	0.038
3	321597	0.037
2	375000	0.036
1	500000	0.035
2	500000	0.034

Price($)	Vol.	No.
0.041	105531	2
0.042	333094	2
0.043	408000	4
0.044	564835	5
0.045	276947	2

Last trade - 16.10pm 28/07/2025 (20 minute delay)

EMD (ASX) Chart

Ann: Emyria secures clinical-grade MDMA supply for Aust patients, page-5

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Clarity confidence – and share price – up on bumper $203M institutional placement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Emyria secures clinical-grade MDMA supply for Aust patients, page-5

Top Stories

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Clarity confidence – and share price – up on bumper $203M institutional placement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News